bs-11770R [Primary Antibody]
TMEM158 Polyclonal Antibody
www.biossusa.com
[email protected]
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET

Host: Rabbit

Target Protein: TMEM158

Immunogen Range: 188-260/300


Clonality: Polyclonal

Isotype: IgG

Entrez Gene: 25907

Swiss Prot: Q8WZ71

Source: KLH conjugated synthetic peptide derived from human TMEM158

Purification: Purified by Protein A.

Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Storage: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Background:

Receptor for brain injury-derived neurotrophic peptide (BINP), a synthetic 13-mer peptide.

Size: 100ul

Concentration: 1ug/ul

Applications: WB(1:300-5000)
ELISA(1:20-100)
IHC-P(1:200-400)
IHC-F(1:100-500)
IF(IHC-P)(1:50-200)
IF(IHC-F)(1:50-200)
IF(ICC)(1:50-200)
ICC(1:100-500)

Predicted Molecular Weight: 28


Cross Reactive Species: Mouse
Rat

Predicted Cross Reactive Species: Human
Cow
Pig
Chicken

For research use only. Not intended for diagnostic or therapeutic use.

VALIDATION IMAGES

Paraformaldehyde-fixed, paraffin embedded rat brain tissue; Antigen retrieval by boiling in sodium citrate buffer(pH6) for 15min; Block endogenous peroxidase by 3% hydrogen peroxide for 20 minutes; Blocking buffer (normal goat serum) at 37°C for 30min; Antibody incubation with TMEM158 Polyclonal Antibody, Unconjugated (bs-11770R) at 1:400 overnight at 4°C, followed by a conjugated secondary and DAB staining


Paraformaldehyde-fixed, paraffin embedded rat brain tissue; Antigen retrieval by boiling in sodium citrate buffer(pH6) for 15min; Block endogenous peroxidase by 3% hydrogen peroxide for 20 minutes; Blocking buffer (normal goat serum) at 37°C for 30min; Antibody incubation with TMEM158 Polyclonal Antibody, Unconjugated (bs-11770R) at 1:200 overnight at 4°C, followed by a conjugated secondary and DAPI staining


Formalin-fixed and paraffin embedded rat brain labeled with Anti-TMEM158 Polyclonal Antibody, Unconjugated (bs-11770R) at 1:200 followed by conjugation to the secondary antibody and DAB staining